These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 38109776)

  • 1. Amidst an amygdala renaissance in Alzheimer's disease.
    Stouffer KM; Grande X; Düzel E; Johansson M; Creese B; Witter MP; Miller MI; Wisse LEM; Berron D
    Brain; 2024 Mar; 147(3):816-829. PubMed ID: 38109776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional mapping of neurofibrillary tangle burden in the human medial temporal lobe.
    Yushkevich PA; Muñoz López M; Iñiguez de Onzoño Martin MM; Ittyerah R; Lim S; Ravikumar S; Bedard ML; Pickup S; Liu W; Wang J; Hung LY; Lasserve J; Vergnet N; Xie L; Dong M; Cui S; McCollum L; Robinson JL; Schuck T; de Flores R; Grossman M; Tisdall MD; Prabhakaran K; Mizsei G; Das SR; Artacho-Pérula E; Arroyo Jiménez MDM; Marcos Raba MP; Molina Romero FJ; Cebada Sánchez S; Delgado González JC; de la Rosa-Prieto C; Córcoles Parada M; Lee EB; Trojanowski JQ; Ohm DT; Wisse LEM; Wolk DA; Irwin DJ; Insausti R
    Brain; 2021 Oct; 144(9):2784-2797. PubMed ID: 34259858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia.
    Lowe VJ; Wiste HJ; Senjem ML; Weigand SD; Therneau TM; Boeve BF; Josephs KA; Fang P; Pandey MK; Murray ME; Kantarci K; Jones DT; Vemuri P; Graff-Radford J; Schwarz CG; Machulda MM; Mielke MM; Roberts RO; Knopman DS; Petersen RC; Jack CR
    Brain; 2018 Jan; 141(1):271-287. PubMed ID: 29228201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early amygdala and ERC atrophy linked to 3D reconstruction of rostral neurofibrillary tau tangle pathology in Alzheimer's disease.
    Stouffer KM; Chen C; Kulason S; Xu E; Witter MP; Ceritoglu C; Albert MS; Mori S; Troncoso J; Tward DJ; Miller MI;
    Neuroimage Clin; 2023; 38():103374. PubMed ID: 36934675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
    Soleimani-Meigooni DN; Iaccarino L; La Joie R; Baker S; Bourakova V; Boxer AL; Edwards L; Eser R; Gorno-Tempini ML; Jagust WJ; Janabi M; Kramer JH; Lesman-Segev OH; Mellinger T; Miller BL; Pham J; Rosen HJ; Spina S; Seeley WW; Strom A; Grinberg LT; Rabinovici GD
    Brain; 2020 Dec; 143(11):3477-3494. PubMed ID: 33141172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age.
    Betthauser TJ; Koscik RL; Jonaitis EM; Allison SL; Cody KA; Erickson CM; Rowley HA; Stone CK; Mueller KD; Clark LR; Carlsson CM; Chin NA; Asthana S; Christian BT; Johnson SC
    Brain; 2020 Jan; 143(1):320-335. PubMed ID: 31886494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.
    Schwarz AJ; Yu P; Miller BB; Shcherbinin S; Dickson J; Navitsky M; Joshi AD; Devous MD; Mintun MS
    Brain; 2016 May; 139(Pt 5):1539-50. PubMed ID: 26936940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-MK-6240 PET for early and late detection of neurofibrillary tangles.
    Pascoal TA; Therriault J; Benedet AL; Savard M; Lussier FZ; Chamoun M; Tissot C; Qureshi MNI; Kang MS; Mathotaarachchi S; Stevenson J; Hopewell R; Massarweh G; Soucy JP; Gauthier S; Rosa-Neto P
    Brain; 2020 Sep; 143(9):2818-2830. PubMed ID: 32671408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.
    Pascoal TA; Benedet AL; Tudorascu DL; Therriault J; Mathotaarachchi S; Savard M; Lussier FZ; Tissot C; Chamoun M; Kang MS; Stevenson J; Massarweh G; Guiot MC; Soucy JP; Gauthier S; Rosa-Neto P
    Brain; 2021 Dec; 144(11):3517-3528. PubMed ID: 34515754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for early vulnerability of the medial and inferior aspects of the temporal lobe in an 82-year-old patient with preclinical signs of dementia. Regional and laminar distribution of neurofibrillary tangles and senile plaques.
    Hof PR; Bierer LM; Perl DP; Delacourte A; Buée L; Bouras C; Morrison JH
    Arch Neurol; 1992 Sep; 49(9):946-53. PubMed ID: 1520086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medial temporal lobe gray matter microstructure in preclinical Alzheimer's disease.
    Brown C; Das S; Xie L; Nasrallah I; Detre J; Chen-Plotkin A; Shaw L; McMillan C; Yushkevich P; Wolk D
    Alzheimers Dement; 2024 Jun; 20(6):4147-4158. PubMed ID: 38747539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "End-stage" neurofibrillary tangle pathology in preclinical Alzheimer's disease: fact or fiction?
    Abner EL; Kryscio RJ; Schmitt FA; Santacruz KS; Jicha GA; Lin Y; Neltner JM; Smith CD; Van Eldik LJ; Nelson PT
    J Alzheimers Dis; 2011; 25(3):445-53. PubMed ID: 21471646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of neurofibrillary tangle immunophenotype signatures to classify tangle maturity in Alzheimer's disease.
    Hamlin D; Ryall C; Turner C; Faull RLM; Murray HC; Curtis MA
    Alzheimers Dement; 2024 Jul; 20(7):4803-4817. PubMed ID: 38884346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in glial cell phenotypes precede overt neurofibrillary tangle formation, correlate with markers of cortical cell damage, and predict cognitive status of individuals at Braak III-IV stages.
    Taddei RN; Sanchez-Mico MV; Bonnar O; Connors T; Gaona A; Denbow D; Frosch MP; Gómez-Isla T
    Acta Neuropathol Commun; 2022 May; 10(1):72. PubMed ID: 35534858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study.
    Josephs KA; Dickson DW; Tosakulwong N; Weigand SD; Murray ME; Petrucelli L; Liesinger AM; Senjem ML; Spychalla AJ; Knopman DS; Parisi JE; Petersen RC; Jack CR; Whitwell JL
    Lancet Neurol; 2017 Nov; 16(11):917-924. PubMed ID: 28919059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential medial temporal lobe and default-mode network functional connectivity and morphometric changes in Alzheimer's disease.
    Grajski KA; Bressler SL;
    Neuroimage Clin; 2019; 23():101860. PubMed ID: 31158694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medial temporal lobe connectivity and its associations with cognition in early Alzheimer's disease.
    Berron D; van Westen D; Ossenkoppele R; Strandberg O; Hansson O
    Brain; 2020 Apr; 143(4):1233-1248. PubMed ID: 32252068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Correlates of the PET-based Braak Staging Framework in Alzheimer's Disease.
    Macedo AC; Durço DFPA; Tissot C; Therriault J; Vilela de Faria AO; Aumont É; Servaes S; Rahmouni N; Fernandez-Arias J; Wang YT; Lussier FZ; Bieger A; Zimmer ER; Pascoal TA; Gauthier S; Rosa-Neto P
    J Prev Alzheimers Dis; 2024; 11(2):414-421. PubMed ID: 38374747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker research.
    Moloney CM; Lowe VJ; Murray ME
    Alzheimers Dement; 2021 Sep; 17(9):1554-1574. PubMed ID: 33797838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.
    Gordon BA; Blazey TM; Christensen J; Dincer A; Flores S; Keefe S; Chen C; Su Y; McDade EM; Wang G; Li Y; Hassenstab J; Aschenbrenner A; Hornbeck R; Jack CR; Ances BM; Berman SB; Brosch JR; Galasko D; Gauthier S; Lah JJ; Masellis M; van Dyck CH; Mintun MA; Klein G; Ristic S; Cairns NJ; Marcus DS; Xiong C; Holtzman DM; Raichle ME; Morris JC; Bateman RJ; Benzinger TLS
    Brain; 2019 Apr; 142(4):1063-1076. PubMed ID: 30753379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.